# Summary of S. 5243: Cannabinoid Safety and Regulation Act
This bill establishes the first federal regulatory framework for cannabinoid products derived from hemp, placing them under Food and Drug Administration (FDA) oversight similar to other food and dietary supplement products. The legislation creates comprehensive labeling requirements, including warnings about THC content, health risks, allergens, and age restrictions, while mandating that manufacturers register facilities and submit products for safety testing by state-certified laboratories that check for pesticides, heavy metals, and contamination.
The bill affects manufacturers, distributors, retailers, and consumers of cannabinoid products containing tetrahydrocannabinol (THC) or other cannabinoids. It prohibits sales to anyone under 21 years old and bans flavored vaping products, cartoon-like shapes that appeal to children, and products that imitate candy or beverages. The legislation authorizes civil penalties up to $15,000 per violation and enhanced penalties of up to $250,000 for knowing violations.
The bill allocates significant funding for public health initiatives: $100 million annually from 2024-2028 for cannabis use surveillance and data collection, $25 million annually for programs preventing youth cannabis use, and $70 million annually (2024-2029) for cannabis-impaired driving research and prevention. It also establishes a state grant program with $40 million annually (2024-2028) to help states develop enforcement and education programs addressing cannabis-impaired driving.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.